Ripasudil zur konservativen Behandlung einer Hornhautdekompensation durch Endothelverlust nach Endotheliitis

Article Properties
  • Language
    German
  • DOI (url)
    10.1055/a-2152-6576
  • Publication Date
    2023/08/11
  • Journal
    Klinische Monatsblätter für Augenheilkunde
  • Indian UGC (journal)
  • Refrences
    5
  • Filip S. Filev Augenheilkunde, GLG Werner Forssmann Klinikum Eberswalde, Deutschland
  • Erik Chankiewitz Augenheilkunde, Städtisches Klinikum Braunschweig gGmbH, Deutschland
  • Tuan Le Augenheilkunde, GLG Werner Forssmann Klinikum Eberswalde, Deutschland
  • Mareike Rockel Augenheilkunde, GLG Werner Forssmann Klinikum Eberswalde, Deutschland
  • Burkhard von Jagow Augenheilkunde, GLG Werner Forssmann Klinikum Eberswalde, Deutschland
Cite
Filev, Filip S., et al. “Ripasudil Zur Konservativen Behandlung Einer Hornhautdekompensation Durch Endothelverlust Nach Endotheliitis”. Klinische Monatsblätter für Augenheilkunde, 2023, https://doi.org/10.1055/a-2152-6576.
Filev, F. S., Chankiewitz, E., Le, T., Rockel, M., & von Jagow, B. (2023). Ripasudil zur konservativen Behandlung einer Hornhautdekompensation durch Endothelverlust nach Endotheliitis. Klinische Monatsblätter für Augenheilkunde. https://doi.org/10.1055/a-2152-6576
Filev FS, Chankiewitz E, Le T, Rockel M, von Jagow B. Ripasudil zur konservativen Behandlung einer Hornhautdekompensation durch Endothelverlust nach Endotheliitis. Klinische Monatsblätter für Augenheilkunde. 2023;.
Journal Categories
Medicine
Medicine (General)
Medicine
Ophthalmology
You May Also Like
Refrences
Title Journal Journal Categories Citations Publication Date
Cell-based approach for treatment of corneal endothelial dysfunction Cornea
  • Medicine: Medicine (General)
  • Medicine: Ophthalmology
 2014
Potential Functional Restoration of Corneal Endothelial Cells in Fuchs Endothelial Corneal Dystrophy by ROCK Inhibitor (Ripasudil) American Journal of Ophthalmology
  • Medicine
  • Medicine: Ophthalmology
  • Medicine: Medicine (General)
 42 2021
Corneal Endothelial Cell Migration and Proliferation Enhanced by Rho Kinase (ROCK) Inhibitors in In Vitro and In Vivo Models Investigative Opthalmology & Visual Science 59 2016
Laminin-511 and -521 Enable Efficient In Vitro Expansion of Human Corneal Endothelial Cells Investigative Opthalmology & Visual Science 54 2015
Ripasudil: First Global Approval Drugs
  • Medicine: Therapeutics. Pharmacology
  • Medicine: Public aspects of medicine: Toxicology. Poisons
  • Medicine: Public aspects of medicine: Toxicology. Poisons
  • Medicine: Public aspects of medicine: Toxicology. Poisons
 152 2014
Refrences Analysis
Category Category Repetition
Medicine: Public aspects of medicine: Toxicology. Poisons3
Medicine: Medicine (General)2
Medicine: Ophthalmology2
Medicine: Therapeutics. Pharmacology1
Medicine1
The category Medicine: Public aspects of medicine: Toxicology. Poisons 3 is the most frequently represented among the references in this article. It primarily includes studies from Drugs and Cornea. The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year